These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Search MEDLINE/PubMed


  • Title: [Lyell's syndrome: proposal for a therapeutic protocol].
    Author: Posadinu MA, Sanna E, Canu V, Ciccarese M, Pala PG, Cossu M.
    Journal: G Ital Nefrol; 2012; 29 Suppl 54():S147-8. PubMed ID: 22388849.
    Abstract:
    Toxic epidermal necrolysis or Lyell's syndrome is a life-threatening, drug-induced disorder characterized by severe epidermal injury. Although plasmapheresis is expensive and requires easy venous access, it could be included in the first-line treatment of toxic epidermal necrolysis. The method is safe and effective, providing prompt relief from pain and rapid cessation of necrolysis. Moreover, in our experience plasmapheresis could be used in patients who were unresponsive to corticosteroids, and in patients with severe clinical symptoms.
    [Abstract] [Full Text] [Related] [New Search]